P6168Digitoxin serum concentrations affecting patient safety and potential outcome in patients with HFrEF - analyses of the ongoing DIGIT-HF-trial

MLA

L. Aguirre Davila, et al. “P6168Digitoxin Serum Concentrations Affecting Patient Safety and Potential Outcome in Patients with HFrEF - Analyses of the Ongoing DIGIT-HF-Trial.” European Heart Journal, vol. 38, Aug. 2017. EBSCOhost, https://doi.org/10.1093/eurheartj/ehx493.p6168.

APA

L. Aguirre Davila, S.A. Phillip, Armin Koch, Lars S. Maier, Kristina Weber, Ralf Westenfeld, Johannes Schwab, S Stoerk, Johann Bauersachs, & Udo Bavendiek. (2017). P6168Digitoxin serum concentrations affecting patient safety and potential outcome in patients with HFrEF - analyses of the ongoing DIGIT-HF-trial. European Heart Journal, 38. https://doi.org/10.1093/eurheartj/ehx493.p6168

Chicago

L. Aguirre Davila, S.A. Phillip, Armin Koch, Lars S. Maier, Kristina Weber, Ralf Westenfeld, Johannes Schwab, S Stoerk, Johann Bauersachs, and Udo Bavendiek. 2017. “P6168Digitoxin Serum Concentrations Affecting Patient Safety and Potential Outcome in Patients with HFrEF - Analyses of the Ongoing DIGIT-HF-Trial.” European Heart Journal 38 (August). doi:10.1093/eurheartj/ehx493.p6168.